In contrast, patients receiving a single course of teplizumab demonstrated a relative increase in C-peptide levels, suggesting not only a delay in beta cell destruction, but also the recovery of sick or dying beta cells and the restoration of their functionality and insulin secretion.
product_or_material_produced: beta cell, insulin